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Abstract
Background—Multiple micronutrient deficiencies are common among women in low-income
countries and may adversely affect pregnancy outcomes Objective To conduct a meta-analysis of
the effects on stillbirths, early and late neonatal mortality of multiple micronutrient (MMN)
compared with iron and folic acid (Fe + FA)supplementation during pregnancy in recent
randomised controlled trials.
Methods—Twelve randomised controlled trials were included in the analysis ( Bangladesh,
Burkina Faso, China, Guinea Bissau, Indonesia, Mexico, Nepal, Niger, Pakistan and Zimbabwe),
all providing approximately 1 Recommended Dietary Allowance (RDA) of MMN or Fe + FA to
presumed HIV-negative women.
Results—MMN supplementation providing approximately 1 RDA of MMN did not decrease the
risk of stillbirths (OR 1.01, 95% CI 0.88-1.16), early neonatal mortality (OR 1.23, 95% CI
0.95-1.59), late neonatal mortality (OR 0.94, 95% CI 0.73-1.23), or perinatal mortality (OR 1.11,
95% CI 0.93-1.33)
Conclusion—Our meta-analysis provides consistent evidence that MMN supplementation
providing approximately 1 RDA of MMN during pregnancy does not result in any reduction in
stillbirths, early or late neonatal deaths compared to FE + FA alone.
Introduction
The World Health Organization recommends universal distribution of Fe + FA supplements
to all pregnant women in developing countries [1]. Because many women face additional
micronutrient deficits, particularly in pregnancy, repletion of pregnant women with minerals
and vitamins has been suggested as a way to further improve birth outcomes in countries
with a high burden of under-nutrition [2]. Daily multiple micronutrients (MMN) during
pregnancy have been shown to reduce the number of low birth weight and small-for-
gestational age babies, and maternal anaemia [3]. A recent meta-analysis of MMN
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supplementation during pregnancy reported a small statistically significant increase in birth
weight when compared with Fe + FA supplementation, but there was no effect on the
incidence of pre-term birth [4]. Another meta-analysis showed reductions in anaemia and Fe
deficiency and several other micronutrient deficiencies with the use of MMN [5].
If MMN affect fetal growth, particularly small-for-gestational-age births [6], a direct
beneficial effect on perinatal or neonatal survival can be hypothesised. A systematic review
of nine trials did not find a significant difference in perinatal mortality when comparing
MMN supplementation with two or less micronutrients, Fe FA supplementation, no
supplementation or placebo [3]. However, two trials in Nepal reported non-significant
increases in perinatal and neonatal death associated with MMN supplementation compared
to women who took only Fe and FA in pregnancy [7]. Although these results have been
called into question [8.9], the possibility of adverse outcomes in relation to MMN
supplementation certainly warrants further investigation.
At the time of the systematic review conducted by Haider and Bhutta [3], a number of trials
of MMN supplementation were still ongoing. The present study updates the review and
assesses the effect of supplementing pregnant women with a daily MMN tablet compared
with Fe + FA on stillbirths, early and late neonatal mortality, and perinatal mortality.
Methods
Search protocol and study review
Details of the search strategy and study review are reported elsewhere [10]. In brief, findings
are reported from randomised controlled trials supplementing pregnant women with daily
MMN. For studies with more than one intervention or control arm only one comparison
group was selected [10]. Table 1 lists the 12 trials included in this review. In brief, nine
studies [10-13,15-19] used the UNICEF/UNU/WHO recommended daily composition of the
multi-micronutrient tablet UNIMMAP (United Nations International Multiple Micronutrient
Preparation), while the studies in Mexico [22], Nepal-Sarlahi [15] and Zimbabwe [21] used
slightly different preparations. The UNIMMAP contains 30 mg Fe, 15 mg zinc, 2 mg
copper, 65 μg selenium, 150 μg iodine, 800 ug RE vitamin A, 1.4 mg vitamin B1, 1.4 mg
vitamin B2, 400 μg folic acid, 18 mg niacin, 1.9 mg vitamin B6, 2.6 μg vitamin B12, 70 mg
vitamin C, 200 IU vitamin D and 10 mg vitamin E. The studies in Nepal-Sarlahi and Mexico
used MMN containing 60 mg of Fe and in Zimbabwe Fe + FA were not included in the
MMN but were supplied separately as part of routine antenatal care
The control regimen consisted of 60 mg Fe and 400μg FA except for the studies in
Indonesia-Lombok and Bangladesh which used 30 mg of Fe. Women in Zimbabwe received
the routine antenatal prescription of Fe + FA. Six trials were cluster randomised and six used
individual randomisation.
Statistical methods
From the selected studies, data were extracted on the number of live and still births and on
early and late neonatal mortality. The Coding of data for fetal loss, still and live births was
accepted from that reported in the data for each study. A stillbirth is defined as the death of a
fetus after 28 weeks’ gestation but before delivery of the baby’s head, which is consistent
with the definition generally used in developing countries. Early neonatal deaths was
defined as death of a live born infant within seven completed days after birth. Late neonatal
death refer to death of an infant between 8 and 28 completed days after birth. Perinatal
mortality was also reported, pooling stillbirths and early neonatal deaths, because early
neonatal deaths may be wrongly registered as stillbirths [23]. Denominators for stillbirths,
early and late neonatal mortality and perinatal mortality are all births (live and stillbirths), all
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live births, all neonates surviving after the first week and all births respectively. Women
were excluded if they were known to be HIV positive, to have multiple pregnancies, foetal
loss or unknown live/stillborn status at birth. Only one pregnancy was included for each
woman.
Statistical analyses and meta-analyses were performed using Stata 10. The overall effect of
MMN supplementation on the risk of stillbirths, early neonatal deaths, perinatal deaths and
late neonatal deaths was assessed. Crude mortality rates in intervention and control arms,
with 95% CI adjusted for clustering where appropriate were also reported. Odds Ratios (OR)
with 95% CI were used as a measure of effect of MMN supplementation on risk of
mortality. Random effects models were used to calculate the pooled OR for MMN
supplementation compared to controls, adjusting for cluster design where appropriate.
Results were presented based on analyses using random-effects models because of the
different levels of mortality, intervention and control regimens, intervention durations and
dietary intake of the study populations. Heterogeneity between studies was measured using
the I-square statistic, and was tested for significance using a chi-square test on the Q
statistic. Because the review was heavily weighted towards the large Indonesia-Lombok
study [14], an priori sensitivity analysis was undertaken by removing this study from the
meta-analysis.
Results
Levels of mortality
There were marked differences in the rate of stillbirths, early neonatal and late neonatal
mortality across studies (Table 2, Figures 1-3). Stillbirth rates in the control arm ranged
from 5.6 per 1000 births in Zimbabwe to over 50 per 1000 births in Pakistan and Guinea
Bissau. Early neonatal mortality was low in Burkina Faso (5.0 per 1000 live births) but
reached a level of 23.5 per 1000 live births in Pakistan. Similarly, for late neonatal mortality
the range was between 1.7 and 15.7 deaths per 1000 children surviving the first week in
Burkina Faso and Pakistan respectively.
Effect of MMN supplementation on stillbirths, early neonatal and perinatal mortality
Of the 12 eligible studies, all provided data on stillbirths and nine on early neonatal deaths
(Niger, Zimbabwe and Mexico did not). Figures 4-6 show the meta-analysis for stillbirths
and early neonatal and perinatal mortality. With a random effects model, MMN
supplementation was not associated with stillbirths (OR 1.01, 95% CI 0.88-1.16), but there
was a non-significant 23% increase in early neonatal mortality (OR 1.23, 95% CI 0.96-1.59)
and a non-significant 11% increase in perinatal mortality (OR 1.11, 95% CI 0.93-1.33).
Between-study heterogeneity was moderate for perinatal mortality (I2=46%, p=0.07) and
early neonatal mortality (I2=34%, p=0.15) but low for stillbirths (I2=3%, p=0.42). Excluding
the large Indonesia-Lombok study increased all relative risk estimates. The subsequent OR
of stillbirths, early neonatal and perinatal mortality were 1.12 (95% CI 0.93-1.34), 1.40
(95% CI 1.08-1.82) and 1.20 (95% CI 1.01-1.42) respectively.
Late neonatal mortality
Data on late neonatal mortality were available for eight studies which included 22,396
children whose mothers received multiple micronutrient supplementation and 22,003
children in the control arm. The pooled data showed a non-significant 6% reduction in late
neonatal mortality (OR 0.94, 95% CI 0.73-1.23) (Figure 7). Heterogeneity was low (I2=0%,
p=0.75) and sensitivity analysis altered the odds ratio slightly (OR=1.01, 95% CI 0.64-1.60).
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Discussion
This meta-analysis provides coherent evidence that MMN supplementation does not result in
any reduction in stillbirths or early and late neonatal deaths. However, after removing the
large Indonesian study from the analysis the data were consistent with an increased risk in
early neonatal and perinatal mortality in women taking MMN supplements during
pregnancy compared to Fe + FA.
The lack of an effect of MMN supplements on perinatal or neonatal survival – and the
possibility of increased early neonatal and perinatal mortality in women taking MMN
supplements in some settings - needs to be scrutinised very carefully. This finding is
surprising given that MMN supplementation does result in small increases in birthweight
[4].
It was expected that there would be a direct beneficial effect on early neonatal and perinatal
survival. Increased survival of infants who would otherwise have died in utero is unlikely
since MMN was not associated with preterm birth [4] or stillbirth. It could be argued that
newborns in the control arm had enhanced survival because most mothers in the control arm
received higher amounts of Fe than the MMN group. There is no evidence however that
routine Fe supplementation in pregnancy improves health outcomes for babies [24].
Huffman and colleagues [8] suggested that the earlier Nepal findings might be due to a
misclassification of stillbirths into neonatal deaths. It was for that reason that perinatal
mortality (pooled stillbirths and early neonatal deaths) was assessed, rather than reporting
only on neonatal mortality. Increased asphyxia of children born at the upper end of the birth
weight distribution [7] may partly explain the adverse effects of MMN supplementation on
perinatal mortality. In Nepal, children whose mothers had received MMN were reported to
have a 60% higher risk of birth asphyxia [32].
Meta-analyses have inherent limitations. First, the sample size of the trials included in this
analysis varied, and the results were more likely to be affected by the trials with larger
sample sizes. However, the only study powered to examine effects on mortality – the
Indonesia Lombok study - also failed to find a statistically significant effect of MMN
supplementation on perinatal or neonatal survival [14]. Second, there was significant
heterogeneity among studies for perinatal mortality, though the source of this heterogeneity
is difficult to ascertain. The study populations differed substantially in terms of nutritional
status, reproductive history and timing and duration of MMN, all of which may affect the
effect of MMN on perinatal mortality. Effects of supplements that include one RDA have
been found to vary in HIV infected and uninfected pregnant women in Tanzania [25],
suggesting that the burden of infectious diseases may affect nutritional requirements and the
size of effect of MMN.
Intervention trials have now expanded the range of endpoints to include neonatal morbidity
[32], mortality after the first month of life [14.26], infant growth and development and
health outcomes later in childhood [25]. In Lombok, Indonesia, early infant mortality after
the first month of life was 30% lower in the MMN group compared to the Fe + FA group
[14]. In Nepal, children whose mothers had taken MMN during pregnancy were heavier and
of greater body size at the age of 2.5 years than those born to mothers who had only received
Fe + FA [27]. In another study in Nepal, MMN supplementation did not improve symptoms
of neonatal morbidity, and reported birth asphyxia was higher in the MMN group [32]. In
the present analysis, data were not available on survival beyond one month and it was not
possible to expand the meta-analysis beyond the neonatal period.
It has been suggested that higher doses of MMN may be required in malnourished
populations [25]. However, the one study involving a supplement containing twice the RDA
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of vitamin E and 6 to 10 times the RDAs for several B vitamins and vitamin C in HIV-
uninfected pregnant women in Tanzania, and which was powered for effects on fetal death,
also had no effect on stillbirths or perinatal mortality [25]. It may be that MMN
supplementation before conception rather than during pregnancy is the way forward.
Periconceptional folic acid supplementation, for example, reduces the incidence of neural
tube defects [27], and there is growing evidence that maternal undernutrition in the
periconceptional period increases the risk of pre-term delivery [29,30], and reduces fetal
growth even if nutrition improves later in pregnancy. Future research should include studies
of maternal nutrient repletion before pregnancy.
What are the implications of our findings for public health? Any suggestion of harm must be
carefully weighed against evidence of potential gain [9]. Improving micronutrient intake
during pregnancy contributes to reduced micronutrient deficiencies in mothers and small
increases in birth weight, and there is some evidence that infant survival after the first month
may be improved. However, MMN supplementation in pregnancy does not lead to a gain in
perinatal survival in the pooled results of 11 studies of women receiving MMN
supplementation, and MMN may increase the risk of birth asphyxia. Three quarters of
neonatal deaths happen in the first week of life, and the burden of mortality in the early
neonatal period is much greater than that in later infancy. There has also been least progress
in reducing deaths during the perinatal period [31]. Given the limited resources available for
public health in poor countries, attention should focus on interventions that are known to
positively reduce the burden of stillbirths and early neonatal mortality. On current evidence,
MMN supplementation started in mid-pregnancy is not one of them. Success in reducing
perinatal deaths is possible through outreach and community care, including health
education to improve home-care practices, to create demand for skilled care and to improve
care seeking. Expansion of skilled care for babies and mothers is essential to achieve the
reduction in neonatal deaths needed to meet the Millennium Development Goal for child
survival.
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Figure 1.
Stillbirths per 1000 births (95% confidence intervals) in Multiple Micronutrient (MMN) and
control groups in each study
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Figure 2.
Early neonatal deaths per 1000 live births (95% confidence intervals) in Multiple
Micronutrient (MMN) and control groups in each study
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Figure 3.
Late neonatal deaths per 1000 children surviving the first week of life (95% confidence
intervals) in Multiple Micronutrient (MMN) and control groups in each study
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Figure 4.
Random effects model forest plots for effects of MMN supplementation on stillbirths
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Figure 5.
Random effects model forest plots for effects of MMN supplementation on early neonatal
deaths
Carine et al. Page 12
Food Nutr Bull. Author manuscript; available in PMC 2012 August 28.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Figure 6.
Random effects model forest plots for effects of MMN supplementation on perinatal
mortality
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Figure 7.
Random effects model forest plots for effects of MMN supplementation on late neonatal
mortality
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